Literature DB >> 14724577

Interaction between JCV large T-antigen and beta-catenin.

Dai-Di Gan1, Kamel Khalili.   

Abstract

Expression of the JCV early protein T-antigen in transgenic mice leads to the development of cerebellar primitive neuroectodermal tumors (PNETs). In light of earlier reports on the association of JCV with PNETs in humans and the involvement of the Wnt signaling pathway in the development of cerebellar tumors, we investigated the interplay between T-antigen and beta-catenin, the key protein of the Wnt pathway. Our results demonstrate the physical interaction of T-antigen with beta-catenin through the central domain of T-antigen spanning residues 82-628, and the C-terminus of beta-catenin located between amino acids 695 and 781. The association of T-antigen with beta-catenin elevates the level of beta-catenin in the cells due to increased in the stability of the protein. In the presence of T-antigen, beta-catenin was found in the nuclei of cells, suggesting that the interaction of beta-catenin with T-antigen facilitates its nuclear import. In cells expressing mutant T-antigen with no nuclear localization domain, beta-catenin was found in the cytoplasm. Coexpression of T-antigen with beta-catenin increased the transcription of the c-myc promoter, a known downstream target of beta-catenin, and artificial promoter whose activity is beta-catenin dependent. These observations ascribe a new oncogenic pathway for T-antigen, and offer an alternative mechanism for the deregulation of the Wnt pathway through stabilization of beta-catenin upon its association with the viral oncoprotein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724577     DOI: 10.1038/sj.onc.1207018

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

Review 1.  Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  JC virus infection: a cause of colorectal cancer?

Authors:  Dana E Rollison
Journal:  J Clin Gastroenterol       Date:  2010-08       Impact factor: 3.062

3.  Human T-cell leukemia virus type 1 tax dysregulates beta-catenin signaling.

Authors:  Mariko Tomita; Akira Kikuchi; Tetsu Akiyama; Yuetsu Tanaka; Naoki Mori
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

4.  JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity.

Authors:  Brigitte Bollag; Catherine A Hofstetter; Marta M Reviriego-Mendoza; Richard J Frisque
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

Review 5.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

6.  Genetic and epigenetic characteristics of gastric cancers with JC virus T-antigen.

Authors:  Satoshi Yamaoka; Hiroyuki Yamamoto; Katsuhiko Nosho; Hiroaki Taniguchi; Yasushi Adachi; Shigeru Sasaki; Yoshiaki Arimura; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

7.  Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.

Authors:  Dana E Rollison; Kathy J Helzlsouer; Ji-Hyun Lee; William Fulp; Sandra Clipp; Judy A Hoffman-Bolton; Anna R Giuliano; Elizabeth A Platz; Raphael P Viscidi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

8.  JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.

Authors:  Katsuhiko Nosho; Kaori Shima; Shoko Kure; Natsumi Irahara; Yoshifumi Baba; Li Chen; Gregory J Kirkner; Charles S Fuchs; Shuji Ogino
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

9.  JC polyomavirus in the aetiology and pathophysiology of glial tumours.

Authors:  Tihomir Eftimov; Yavor Enchev; Iliya Tsekov; Plamen Simeonov; Zlatko Kalvatchev; Elitsa Encheva
Journal:  Neurosurg Rev       Date:  2015-11-12       Impact factor: 3.042

Review 10.  Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.

Authors:  Sarah Beltrami; Richard Kim; Jennifer Gordon
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.